Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
TBK1/IKKε-IN-3
Cat. No.:
OB0425LY-077
Appearance:
Solid
Purity:
≥95%
Identity:
Confirmed by NMR.
Size:
Add to basket
Product Overview
Description:
TBK1/IKKε-IN-3 is a small molecule inhibitor that specifically inhibits key signaling molecules such as TBK1 and IKKε.
Synonyms:
(2E)-3-(3-Phenylbenzo[c]isoxazol-5-yl)prop-2-enoic acid; 851814-28-3; (E)-3-(3-Phenyl-2,1-benzoxazol-5-yl)prop-2-enoic acid; (2E)-3-(3-Phenyl-2,1-benzoxazol-5-yl)prop-2-enoic acid
CAS No.:
851814-28-3
Compound CID:
2517760
Formula:
C16H11NO3
Formula Weight:
265.26
Specification
Target:
Others
Pathway:
Others
Storage:
Storage at -20°C.
Applications:
TBK1/IKKε-IN-3 can be used for obesity research and inflammation-related diseases.
